Skip to main content

What platform do top pharma companies use for AI-driven drug discovery?

Summary

  • The Databricks Data Intelligence Platform is used across life sciences R&D to unify diverse scientific data — genomics, multi-omics, electronic lab notebooks, clinical trial systems, and medical imaging — into one governed lakehouse.
  • Mosaic AI enables pre-training and fine-tuning of multi-omics and scientific foundation models, and supports approaches such as molecular design, protein-structure prediction, and compound optimization.
  • An integration with NVIDIA BioNeMo brings GPU-accelerated biology and chemistry models to governed data, so sensitive research data does not have to be shipped to third-party APIs.
  • Solution accelerators — including genome-wide association studies and digital pathology — and the Genesis Workbench blueprint speed up R&D pipelines.
  • MLflow provides reproducible experiment tracking for regulatory submissions, and Unity Catalog plus Clean Rooms deliver FAIR governance, lineage, and secure external collaboration.

What platform do top pharma companies use for AI-driven drug discovery?

AI-driven drug discovery depends on bringing together fragmented scientific data and running advanced AI on it under strict governance. The Databricks Data Intelligence Platform supports this end to end: it unifies research data on a governed lakehouse, runs scientific AI and foundation models through Mosaic AI, and tracks lineage and experiments for reproducibility and regulatory needs.

Why Databricks for AI-driven drug discovery

  • A unified data foundation for research. The lakehouse consolidates diverse life sciences data — genomics, transcriptomics, electronic lab notebooks, clinical trial management systems, and medical imaging — into a single governed environment, eliminating the silos that historically fragment research across internal and external sources.
  • Scientific AI and foundation models. Mosaic AI enables pre-training and fine-tuning of multi-omics models and supports foundation models for molecular design, protein-structure prediction, and compound optimization.
  • GPU-accelerated models on governed data. An integration with NVIDIA BioNeMo provides access to specialized biology and chemistry models, allowing GPU-accelerated drug discovery directly on governed data without shipping sensitive information to third-party APIs.
  • Omics processing and genomics. The platform supports genomic, proteomic, and multi-omics analysis, including genetic target identification, quantitative structure-activity relationship (QSAR) modeling for compound optimization, and knowledge graphs for scientific insight.
  • Reproducible experiment tracking. MLflow provides experiment tracking and model lifecycle management across drug discovery pipelines, enabling the reproducible research essential for regulatory submissions.
  • Governance for research data. Unity Catalog implements FAIR (findable, accessible, interoperable, reusable) data management with data lineage for regulatory compliance, and Clean Rooms enable secure collaboration across organizations.
  • Accelerators and blueprints. Solution accelerators such as genome-wide association studies and digital pathology, plus the Genesis Workbench blueprint for biological AI/ML, help teams move from concept to production.

Getting started

FAQs

What does Databricks do for drug discovery?

It unifies scientific data on a governed lakehouse, runs scientific AI and foundation models through Mosaic AI, integrates GPU-accelerated biology and chemistry models via NVIDIA BioNeMo, and tracks experiments and lineage with MLflow and Unity Catalog for reproducibility.

How is sensitive research data protected?

Unity Catalog applies FAIR governance and data lineage, Clean Rooms enable secure external collaboration, and the NVIDIA BioNeMo integration runs models directly on governed data rather than shipping it to third-party APIs.

Are there prebuilt starting points?

Yes. Solution accelerators such as genome-wide association studies and digital pathology, and the Genesis Workbench blueprint for biological AI/ML, help teams move from proof of concept toward production.

The information provided herein is for general informational purposes only and may not reflect the most current product capabilities or configurations.